Cargando…
Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582342/ http://dx.doi.org/10.1186/2049-3258-73-S1-P5 |
| _version_ | 1782391687219249152 |
|---|---|
| author | Goossens, Maria (Mieke) Zeegers, Maurice Van Poppel, Hendrik Joniau, Steven Ackaert, Koen Ameye, Filip Billiet, Ignace Dillen, Kurt Goeman, Lieven Van Bruwaene, Siska Van der Aa, Frank Vekemans, Kris Buntinx, Frank |
| author_facet | Goossens, Maria (Mieke) Zeegers, Maurice Van Poppel, Hendrik Joniau, Steven Ackaert, Koen Ameye, Filip Billiet, Ignace Dillen, Kurt Goeman, Lieven Van Bruwaene, Siska Van der Aa, Frank Vekemans, Kris Buntinx, Frank |
| author_sort | Goossens, Maria (Mieke) |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4582342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45823422015-09-28 Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) Goossens, Maria (Mieke) Zeegers, Maurice Van Poppel, Hendrik Joniau, Steven Ackaert, Koen Ameye, Filip Billiet, Ignace Dillen, Kurt Goeman, Lieven Van Bruwaene, Siska Van der Aa, Frank Vekemans, Kris Buntinx, Frank Arch Public Health Poster Presentation BioMed Central 2015-09-17 /pmc/articles/PMC4582342/ http://dx.doi.org/10.1186/2049-3258-73-S1-P5 Text en Copyright © 2015 Goossens et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Goossens, Maria (Mieke) Zeegers, Maurice Van Poppel, Hendrik Joniau, Steven Ackaert, Koen Ameye, Filip Billiet, Ignace Dillen, Kurt Goeman, Lieven Van Bruwaene, Siska Van der Aa, Frank Vekemans, Kris Buntinx, Frank Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title | Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title_full | Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title_fullStr | Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title_full_unstemmed | Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title_short | Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT) |
| title_sort | phase iii randomised chemoprevention study of selenium on the recurrence of non-invasive bladder cancer. the selenium and bladder cancer trial (seleblat) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582342/ http://dx.doi.org/10.1186/2049-3258-73-S1-P5 |
| work_keys_str_mv | AT goossensmariamieke phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT zeegersmaurice phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT vanpoppelhendrik phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT joniausteven phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT ackaertkoen phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT ameyefilip phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT billietignace phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT dillenkurt phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT goemanlieven phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT vanbruwaenesiska phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT vanderaafrank phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT vekemanskris phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat AT buntinxfrank phaseiiirandomisedchemopreventionstudyofseleniumontherecurrenceofnoninvasivebladdercancertheseleniumandbladdercancertrialseleblat |